ArticleOncogene2022

HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotin.

Marco Biondini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.